# Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Non-Fasting Conditions

> **NCT01372358** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 32 (actual)

## Conditions studied

- Fed

## Interventions

- **DRUG:** CIPRO®XR

## Key facts

- **NCT ID:** NCT01372358
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2005-01
- **Final completion:** 2005-02
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2011-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01372358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01372358, "Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Non-Fasting Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01372358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
